Multikine Drug Analysis and Forecasts 2017-2026 - ResearchAndMarkets.com

DUBLIN--()--The "Drug Analysis: Multikine" drug pipelines has been added to ResearchAndMarkets.com's offering.

Multikine is an investigational immunomodulator composed of a proprietary cocktail of naturally occurring cytokines such as interleukins, interferons, chemokines, and colony-stimulating factors. The therapy is administered prior to front-line surgery or radiotherapy. It is designed to activate anti-tumor immune responses and to increase tumor susceptibility to radiotherapy and chemotherapy.

Key Topics Covered:

Product Profiles

Multikine: Head and neck cancer

List of Figures

Figure 1: Multikine for head and neck cancer - SWOT analysis

Figure 2: Drug assessment summary of Multikine for SCCHN

Figure 3: Drug assessment summary of Multikine for SCCHN

Figure 4: Multikine sales for SCCHN across the US, Japan, and five major EU markets, by country, 2017-2026

List of Tables

Table 1: Multikine drug profile

Table 2: Multikine Phase III trials in head and neck cancer

Table 3: Multikine early-phase data in head and neck cancer

Table 4: Multikine sales for SCCHN across the US, Japan, and five major EU markets, by country ($m), 2017-2026

Table 5: Multikine patient numbers for SCCHN across the US, Japan, and five major EU markets, by country, 2017-2026

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/5glzdt/multikine_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs